Topics

Adult-type Diffuse Gliomas | Treatment | Clinical trials | CAR-T-Cells

Home > Publications > Topics > Adult-type Diffuse Gliomas > Treatment > Clinical trials > CAR-T-Cells

Li X, Shang X, Liu J, Zhang Y, Jia X, Li H, Wang Y, Gao J, Ma X, Zhang X, Rong X, Gan W, Zhang Y, Chen J, Wang L, Bao Z, He L, Yan X, Liu Y, Shao J, Xiao Z, Wang Z, Zhu H, Wang Z, Wu Y, Huang Y.
Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial.
Nat Commun. 2026 Jan 6. doi: 10.1038/s41467-025-68112-6. PMID: 41495049. Interventional study. ˍ